NP Thyroid 120
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76420-570 -
Package NDC
76420-570-01 -
Package NDC
76420-570-30 -
Package NDC
76420-570-60 -
Package NDC
76420-570-90 -
SPL ID
fbc96c09-33f1-aa6b-e053-6294a90ae779 -
SPL set ID
19b66f94-a3e1-4f73-ad9b-726036d2cb0b -
UNII
Q51BO43MG4 -
UNII
06LU7C9H1V -
RxCUI
208545 -
RxCUI
1923809
What the source publishes
- Labeler
- Asclemed USA, Inc.
- Active ingredients
- LEVOTHYROXINE, LIOTHYRONINE
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- UNAPPROVED DRUG OTHER
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "NP Thyroid 120",
"splId": "fbc96c09-33f1-aa6b-e053-6294a90ae779",
"labels": [
{
"setId": "19b66f94-a3e1-4f73-ad9b-726036d2cb0b",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=19b66f94-a3e1-4f73-ad9b-726036d2cb0b",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=19b66f94-a3e1-4f73-ad9b-726036d2cb0b"
}
],
"routes": [
"ORAL"
],
"labeler": "Asclemed USA, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (76420-570-01)",
"package_ndc": "76420-570-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20230516"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (76420-570-30)",
"package_ndc": "76420-570-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20230516"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (76420-570-60)",
"package_ndc": "76420-570-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20230516"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (76420-570-90)",
"package_ndc": "76420-570-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20230516"
}
],
"productId": "76420-570_fbc96c09-33f1-aa6b-e053-6294a90ae779",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "76420-570",
"deaSchedule": null,
"genericName": "LEVOTHYROXINE, LIOTHYRONINE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LEVOTHYROXINE",
"strength": "76 ug/1"
},
{
"name": "LIOTHYRONINE",
"strength": "18 ug/1"
}
],
"applicationNumber": null,
"marketingCategory": "UNAPPROVED DRUG OTHER",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20170612",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175945",
"M0021504",
"N0000175946",
"M0021977"
],
"unii": [
"Q51BO43MG4",
"06LU7C9H1V"
],
"rxcui": [
"208545",
"1923809"
],
"spl_set_id": [
"19b66f94-a3e1-4f73-ad9b-726036d2cb0b"
],
"pharm_class_cs": [
"Thyroxine [CS]",
"Triiodothyronine [CS]"
],
"pharm_class_epc": [
"l-Thyroxine [EPC]",
"l-Triiodothyronine [EPC]"
],
"manufacturer_name": [
"Asclemed USA, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76420-570_fbc96c09-33f1-aa6b-e053-6294a90ae779"